Clicky

Friday, November 6, 2026

Breaking News

Latest SEC filings as they come in

Federal Home Loan Mortgage Corp. Files ABS-15G Report

Federal Home Loan Mortgage Corp. submits ABS-15G report detailing third-party due diligence findings on commercial mortgage-backed securities.

UBS AG files preliminary pricing for new yield notes linked to Micron

UBS AG has filed a preliminary pricing supplement for its Trigger Autocallable Contingent Yield Notes linked to Micron Technology, indicating a strategic move.

UBS AG Files Pricing Supplement for New Yield Notes

UBS AG has filed a preliminary pricing supplement for Trigger Autocallable Contingent Yield Notes linked to SpaceX stock, signaling a new investment strategy.

Harvey Rory files to sell over 16,500 shares of GM stock

Harvey Rory of General Motors has filed to sell over 16,500 shares of GM stock, reflecting trends in executive compensation in the automotive industry.

BNY Mellon ETF Trust II Announces Adviser Consolidation

BNY Mellon ETF Trust II plans to consolidate its investment advisers into BNY Investments Corporation, effective January 1, 2027, as part of a branding initiative.

UBS AG launches $200,000 Trigger Autocallable Notes

UBS AG has introduced $200,000 Trigger Autocallable Contingent Yield Notes linked to Meta Platforms, Inc., diversifying its financial offerings.

UBS AG offers $480,000 in Trigger Autocallable Notes

UBS AG has filed a pricing supplement for $480,000 in Trigger Autocallable Contingent Yield Notes linked to Micron Technology's stock.

Mirum Pharmaceuticals' Christopher Peetz to Sell 20,000 Shares

Christopher Peetz of Mirum Pharmaceuticals plans to sell 20,000 shares as part of stock option exercises, reflecting ongoing liquidity management.

Bank of America announces new autocallable notes offering

Bank of America Corp has filed to offer new autocallable leveraged index return notes, linked to key stocks, enhancing its product offerings.

Design Therapeutics boosts common stock offering to $200M

Design Therapeutics increases its common stock offering to $200 million, reflecting confidence in the pharmaceutical sector and strong market demand.

UBS AG launches $775,000 Trigger Autocallable Notes

UBS AG files for $775,000 in Trigger Autocallable Contingent Yield Notes linked to SpaceX, highlighting risks and opportunities in national commercial banking.

Intuitive Surgical Director Craig Barratt Sells 1,150 Shares

Craig H. Barratt, director at Intuitive Surgical, sells 1,150 shares valued at $506,862, reflecting ongoing financial activities within the company.

Quantinno Deals Excelsior Custom Series Files New Private Offering

Quantinno Deals Excelsior Custom Series, L.P. - Series QE0059 files Form D for a private offering, raising over $10 million in investments.

Dempsey Tyler B to Sell 25,000 Shares of Repay Holdings

Dempsey Tyler B has filed to sell 25,000 shares of Repay Holdings Corp, valued at $118,768, reflecting ongoing activity in the business services sector.

UBS AG offers $100,000 Trigger Autocallable Notes linked to META

UBS AG files to offer $100,000 Trigger Autocallable Contingent Yield Notes linked to Meta Platforms, signaling a strategic investment move.

MitoAI Inc. files new offering to raise $8 million

MitoAI Inc. has filed a new offering under Rule 506(b) to raise nearly $8 million, signaling growth ambitions in the technology sector.

AppFolio's Major Stockholder Sells 2,200 Shares of Common Stock

AppFolio Inc. reports a significant stock sale by major shareholder Maurice Duca, impacting the prepackaged software industry.

Zerbe to Sell 2,500 Shares of Vericel Corp After Option Exercise

Dr. Robert L. Zerbe plans to sell 2,500 shares of Vericel Corp, following a stock option exercise, highlighting activity in the biological products sector.

BNY Mellon ETF Trust II Announces Adviser Consolidation Plans

BNY Mellon ETF Trust II plans to consolidate its investment advisory firms into BNY Investments Corporation, effective January 1, 2027.

AppFolio reports major stock sale by key shareholder

AppFolio Inc. discloses a significant stock sale by Maurice J. Duca, valued at $357,984, reflecting ongoing trading activity within the company.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →